EVOKE WEALTH, LLC

Position in KALV — KalVista Pharmaceuticals, Inc.

CIK 1793432 Los Angeles, CA

Position in KALV

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$634,940

+$120,708 QoQ

Shares Held

31,542

-0.9% QoQ

Ownership

0.059%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#93

of 182 holders

Holding Since

Dec 2021

13 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

EVOKE WEALTH, LLC holds $4,430,822 across 13 Biotechnology names. KALV ranks #4 (14.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	1,150	$888,536
2	INCY	Incyte Corp	8,503	$800,302
3	VRTX	Vertex Pharmaceuticals Inc / Ma	1,485	$663,111
4	KALV	KalVista Pharmaceuticals, Inc. This page	31,542	$634,940
5	BMRN	Biomarin Pharmaceutical Inc	4,890	$276,236
6	EXEL	Exelixis, Inc.	5,807	$249,062
7	ALNY	Alnylam Pharmaceuticals, Inc.	693	$229,292
8	SMMT	Summit Therapeutics Inc.	10,668	$202,265

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$634,940	31,542	-0.9%	Shares	Sole	2026-05-15
2025-12-31	$514,232	31,841	-0.7%	Shares	Sole	2026-02-06
2025-09-30	$390,405	32,053	-0.4%	Shares	Sole	2025-11-14
2025-06-30	$363,806	32,181	-0.8%	Shares	Sole	2025-08-07
2025-03-31	$374,426	32,446	+0.3%	Shares	Sole	2025-05-13
2024-12-31	$274,114	32,363	0.0%	Shares	Sole	2025-02-10
2024-09-30	$374,763	32,363	+110.5%	Shares	Sole	2024-11-13
2024-06-30	$181,093	15,373	-39.9%	Shares	Sole	2024-08-13
2022-12-31	$172,941	25,583	0.0%	Shares	Sole	2023-02-10
2022-09-30	$371,209	25,583	0.0%	Shares	Sole	2022-11-07
2022-06-30	$251,736	25,583	0.0%	Shares	Sole	2022-08-04
2022-03-31	$377,093	25,583	0.0%	Shares	Sole	2022-05-10
2021-12-31	$338,463	25,583	—	Shares	Sole	2022-02-09
No filing history on record for this holder in this stock.